Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuitive Surgical
ISRG
|
+$828M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$788M |
| 3 |
Qualcomm
QCOM
|
+$771M |
| 4 |
Apple
AAPL
|
+$719M |
| 5 |
Baxter International
BAX
|
+$571M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.57B |
| 2 |
Wells Fargo
WFC
|
+$967M |
| 3 |
KKR & Co
KKR
|
+$455M |
| 4 |
Booking.com
BKNG
|
+$401M |
| 5 |
GGP
GGP Inc.
GGP
|
+$384M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.16% |
| 2 | Healthcare | 9.53% |
| 3 | Financials | 9.25% |
| 4 | Consumer Discretionary | 7.98% |
| 5 | Communication Services | 7.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMMU
2301
DELISTED
Immunomedics Inc
IMMU
| $11M | ﹤0.01% |
525,956
-43,622
| -8% | -$1.03M |
|
2302
iShares S&P India Nifty 50 Index Fund
INDY
$569M
| $10.9M | ﹤0.01% |
319,911
+30,043
| +10% | +$1.09M |
|
2303
iShares MSCI Netherlands ETF
EWN
$637M
| $10.9M | ﹤0.01% |
361,326
-726
| -0.2% | -$22.5K |
|
|
GPMT
2304
Granite Point Mortgage Trust
GPMT
$61.2M
| $10.9M | ﹤0.01% |
564,273
-89,206
| -14% | -$1.68M |
|
2305
Bright Horizons
BFAM
$3.86B
| $10.8M | ﹤0.01% |
91,944
+21,512
| +31% | +$2.43M |
|
2306
Invesco China Technology ETF
CQQQ
$3.22B
| $10.8M | ﹤0.01% |
225,174
-179,327
| -44% | -$9.17M |
|
2307
Vanguard S&P Small-Cap 600 Growth ETF
VIOG
$1.08B
| $10.8M | ﹤0.01% |
124,722
-16,772
| -12% | -$1.45M |
|
2308
iShares MSCI Poland ETF
EPOL
$756M
| $10.8M | ﹤0.01% |
453,045
+34,567
| +8% | +$810K |
|
2309
Oshkosh
OSK
$9.59B
| $10.8M | ﹤0.01% |
151,720
-93,061
| -38% | -$6.7M |
|
|
NIE
2310
Virtus Equity & Convertible Income Fund
NIE
$732M
| $10.8M | ﹤0.01% |
470,853
-206,180
| -30% | -$4.77M |
|
|
GBT
2311
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $10.8M | ﹤0.01% |
284,382
+35,878
| +14% | +$1.59M |
|
2312
Halozyme
HALO
$12.2B
| $10.8M | ﹤0.01% |
594,639
-297,764
| -33% | -$5.22M |
|
|
IBDQ
2313
DELISTED
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
| $10.8M | ﹤0.01% |
451,856
+89,499
| +25% | +$2.15M |
|
2314
LGI Homes
LGIH
$1.4B
| $10.8M | ﹤0.01% |
227,658
+41,482
| +22% | +$2.28M |
|
2315
MBIA
MBI
$260M
| $10.8M | ﹤0.01% |
1,010,223
-190,615
| -16% | -$1.95M |
|
2316
Alarm.com
ALRM
$2.85B
| $10.8M | ﹤0.01% |
188,115
+75,244
| +67% | +$3.78M |
|
2317
ALPS Medical Breakthroughs ETF
SBIO
$215M
| $10.8M | ﹤0.01% |
274,220
+120,161
| +78% | +$4.56M |
|
|
VSTO
2318
DELISTED
Vista Outdoor Inc.
VSTO
| $10.8M | ﹤0.01% |
602,603
+401,494
| +200% | +$6.89M |
|
|
CLVS
2319
DELISTED
Clovis Oncology, Inc.
CLVS
| $10.8M | ﹤0.01% |
366,522
-41,354
| -10% | -$1.6M |
|
2320
CareDx
CDNA
$2.42B
| $10.7M | ﹤0.01% |
372,574
+302,487
| +432% | +$5.66M |
|
2321
First Trust S&P REIT Index Fund
FRI
$196M
| $10.7M | ﹤0.01% |
460,901
+165,342
| +56% | +$3.91M |
|
2322
Davis Select Financial ETF
DFNL
$491M
| $10.7M | ﹤0.01% |
434,492
+43,626
| +11% | +$1.08M |
|
2323
Archrock
AROC
$5.8B
| $10.7M | ﹤0.01% |
879,720
+479,579
| +120% | +$6.05M |
|
2324
TD Synnex
SNX
$20.2B
| $10.7M | ﹤0.01% |
253,280
+29,062
| +13% | +$1.4M |
|
2325
SSR Mining
SSRM
$6.48B
| $10.7M | ﹤0.01% |
1,231,032
+549,539
| +81% | +$5.19M |
|
Similar funds
Morgan Stanley's Q3 2018 Portfolio in Review
As of Q3 2018, Morgan Stanley held 7,051 positions worth $400B, up 7.9% from $370B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Morgan Stanley's Q3 2018 filing shows 207 new, 2,867 increased, 3,206 reduced and 165 closed positions. Its largest new stake was Elanco Animal Health: 9,012,591 shares worth $314M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.57B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q3 2018 buy was Elanco Animal Health: 9,012,591 shares worth $314M.
- Morgan Stanley added most to Intuitive Surgical in Q3 2018, an estimated $828M increase.
- Morgan Stanley's biggest Q3 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.57B.
- Morgan Stanley fully exited GGP Inc. in Q3 2018, selling an estimated $384M.
- Morgan Stanley's ten largest holdings make up 15% of its $400B portfolio in Q3 2018.
- Morgan Stanley opened 207 new positions and closed 165 in Q3 2018.
- Morgan Stanley's portfolio value rose 7.9% quarter-over-quarter to $400B.
Based on Morgan Stanley's 13F filing for Q3 2018, filed 14 Nov 2018.